Pre-treatment: Measure morning resting heart rate for 5 days Calculate average baseline Record any existing caffeine or stimulant use During treatment: Measure resting heart rate 3 times weekly during dose escalation Continue at each dose for minimum 4 weeks before increasing If resting HR exceeds baseline by more than 15 BPM, hold dose for an additional 2 weeks If resting HR exceeds 100 BPM at rest on two or more measurements, consult physician Expected timeline: Weeks 1-8: minimal heart rate change at starting doses Weeks 8-24: gradual increase of 5-10 BPM at therapeutic doses Weeks 24+: stabilization and gradual decline toward baseline This is the approach most researchers follow successfully, and it aligns with the standard retatrutide dosing protocol used in clinical trials
It works by mimicking a natural hormone that targets areas of the brain involved in appetite regulation
This 2026 safety guide will help you understand the reality of your treatment, moving past the internet noise to provide expert medical strategies for mitigation and long-term safety under clinical supervision
The effect of GLP-1 receptor agonist exenatide on intracranial pressure and headache in idiopathic intracranial hypertension
You start a weight loss program, you get in the middle of it, you stop, you gain the weight back, Pierre said
Residents say that TrimRx gave them the push they needed to stay committed
